Celcuity Inc $CELC

Recent News (6)

• Celcuity To Participate in Upcoming Investor Conferences GlobeNewswire · 01 Sep 2026 MINNEAPOLIS, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a biotechnology company focused on developing and commercializing targeted therapies for the treatment of multiple solid…
• Celcuity (CELC): Landmark Approval Collides With A Costly Launch Yahoo Finance · 27 Aug 2026 Celcuity (CELC): Landmark Approval Collides With A Costly Launch
• Celcuity submits application for breast cancer drug expansion Investing.com · 26 Aug 2026 Celcuity submits application for breast cancer drug expansion
• Celcuity Submits sNDA to FDA for REVTORPYK™ (gedatolisib) for HR+/HER2-, PIK3CA Mutant Locally Advanced or Metastatic Breast Cancer GlobeNewswire · 26 Aug 2026 MINNEAPOLIS, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a biotechnology company focused on developing and commercializing targeted therapies for multiple solid tumor indications…
• Stifel cuts Celcuity stock price target on refined market model Investing.com · 14 Aug 2026 Stifel cuts Celcuity stock price target on refined market model
• CELC Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Celcuity Inc. (NASDAQ: CELC) Investors to Contact the Firm PR Newswire · 31 Jul 2026 RADNOR, Pa., July 31, 2026 /PRNewswire/ -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the feder…